Header Logo

Connection

SETH LERNER to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about Angiogenesis Inhibitors.
SETH LERNER
Connection Strength
0.047
Angiogenesis Inhibitors
  1. The preclinical activity of lenalidomide in indolent urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3383-9.
    View in: PubMed
    Score: 0.025
  2. Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer. Clin Genitourin Cancer. 2013 Jun; 11(2):175-81.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.